-
1
-
-
77955106320
-
Hypoxia inducible factor 1 α (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
-
Dales JP, Beaufils N, Silvy M, Picard C, Pauly V, Pradel V, Formisano-Tréziny C, Bonnier P, Giusiano S, Charpin C, Gabert J. Hypoxia inducible factor 1 α (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer. BMC Med 2010, 8:44.
-
(2010)
BMC Med
, vol.8
, pp. 44
-
-
Dales, J.P.1
Beaufils, N.2
Silvy, M.3
Picard, C.4
Pauly, V.5
Pradel, V.6
Formisano-Tréziny, C.7
Bonnier, P.8
Giusiano, S.9
Charpin, C.10
Gabert, J.11
-
2
-
-
68049105076
-
Role of hypoxia in the hallmarks of human cancer
-
10.1002/jcb.22214, 19479945
-
Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009, 107:1053-1062. 10.1002/jcb.22214, 19479945.
-
(2009)
J Cell Biochem
, vol.107
, pp. 1053-1062
-
-
Ruan, K.1
Song, G.2
Ouyang, G.3
-
3
-
-
26444466467
-
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
-
10.1016/j.radonc.2005.06.038, 16098619
-
Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005, 77:18-24. 10.1016/j.radonc.2005.06.038, 16098619.
-
(2005)
Radiother Oncol
, vol.77
, pp. 18-24
-
-
Nordsmark, M.1
Bentzen, S.M.2
Rudat, V.3
Brizel, D.4
Lartigau, E.5
Stadler, P.6
Becker, A.7
Adam, M.8
Molls, M.9
Dunst, J.10
Terris, D.J.11
Overgaard, J.12
-
4
-
-
0036467638
-
Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer
-
10.1200/JCO.20.3.680, 11821448
-
Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002, 20:680-687. 10.1200/JCO.20.3.680, 11821448.
-
(2002)
J Clin Oncol
, vol.20
, pp. 680-687
-
-
Fyles, A.1
Milosevic, M.2
Hedley, D.3
Pintilie, M.4
Levin, W.5
Manchul, L.6
Hill, R.P.7
-
5
-
-
34748860952
-
Hypoxic radiosensitization: adored and ignored
-
10.1200/JCO.2007.12.7878, 17827455
-
Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 2007, 25:4066-4074. 10.1200/JCO.2007.12.7878, 17827455.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4066-4074
-
-
Overgaard, J.1
-
6
-
-
70350097618
-
Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia
-
Hoogsteen IJ, Lok J, Marres HA, Takes RP, Rijken PF, van der Kogel AJ, Kaanders JH. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. Eur J Cancer 2009, 45:2904-2916.
-
(2009)
Eur J Cancer
, vol.45
, pp. 2904-2916
-
-
Hoogsteen, I.J.1
Lok, J.2
Marres, H.A.3
Takes, R.P.4
Rijken, P.F.5
van der Kogel, A.J.6
Kaanders, J.H.7
-
7
-
-
33646454133
-
Trans-Tasman Radiation Oncology Group Study 98.02. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02
-
10.1200/JCO.2005.05.2878, 16648512
-
Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, Peters LJ. Trans-Tasman Radiation Oncology Group Study 98.02. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006, 24:2098-2104. 10.1200/JCO.2005.05.2878, 16648512.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2098-2104
-
-
Rischin, D.1
Hicks, R.J.2
Fisher, R.3
Binns, D.4
Corry, J.5
Porceddu, S.6
Peters, L.J.7
-
8
-
-
26444467146
-
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
-
10.1016/S1470-2045(05)70292-8, 16198981, Danish Head and Neck Cancer Study Group
-
Overgaard J, Eriksen JG, Nordsmark M, Alsner J, Horsman MR, . Danish Head and Neck Cancer Study Group Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol 2005, 6:757-764. 10.1016/S1470-2045(05)70292-8, 16198981, Danish Head and Neck Cancer Study Group.
-
(2005)
Lancet Oncol
, vol.6
, pp. 757-764
-
-
Overgaard, J.1
Eriksen, J.G.2
Nordsmark, M.3
Alsner, J.4
Horsman, M.R.5
-
9
-
-
35148828429
-
Hypoxia-inducible factor 1 (HIF-1) pathway
-
Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007, 407:cm8.
-
(2007)
Sci STKE
, vol.407
-
-
Semenza, G.L.1
-
10
-
-
39449090004
-
Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies
-
10.2174/092986708783497391, 18288988
-
Bache M, Kappler M, Said HM, Staab A, Vordermark D. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Curr Med Chem 2008, 15:322-338. 10.2174/092986708783497391, 18288988.
-
(2008)
Curr Med Chem
, vol.15
, pp. 322-338
-
-
Bache, M.1
Kappler, M.2
Said, H.M.3
Staab, A.4
Vordermark, D.5
-
11
-
-
33751277287
-
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
-
10.1158/1078-0432.CCR-06-0480, 17085655
-
Brennan DJ, Jirstrom K, Kronblad A, Milikan RC, Landberg G, Duffy MJ, Ryden L, Gallagher WM, O'Brien SL. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006, 12:6421-6431. 10.1158/1078-0432.CCR-06-0480, 17085655.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6421-6431
-
-
Brennan, D.J.1
Jirstrom, K.2
Kronblad, A.3
Milikan, R.C.4
Landberg, G.5
Duffy, M.J.6
Ryden, L.7
Gallagher, W.M.8
O'Brien, S.L.9
-
12
-
-
0037443587
-
Levels of hypoxia-inducible factor-1a independently predict prognosis in patients with lymph node negative breast carcinoma
-
10.1002/cncr.11246, 12627523
-
Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E. Levels of hypoxia-inducible factor-1a independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003, 97:1573-1581. 10.1002/cncr.11246, 12627523.
-
(2003)
Cancer
, vol.97
, pp. 1573-1581
-
-
Bos, R.1
van der Groep, P.2
Greijer, A.E.3
Shvarts, A.4
Meijer, S.5
Pinedo, H.M.6
Semenza, G.L.7
van Diest, P.J.8
van der Wall, E.9
-
13
-
-
0033405294
-
The hypoxic cell: a target for selective cancer therapy - eighteenth Bruce Cain Memorial Award lecture
-
Brown JM. The hypoxic cell: a target for selective cancer therapy - eighteenth Bruce Cain Memorial Award lecture. Cancer Res 1999, 59:5863-5870.
-
(1999)
Cancer Res
, vol.59
, pp. 5863-5870
-
-
Brown, J.M.1
-
14
-
-
70349673606
-
Inhibiting the hypoxia response for cancer therapy: the new kid on the block
-
10.1158/1078-0432.CCR-09-1650, 19789327
-
Koh MY, Spivak-Kroizman TR, Powis G. Inhibiting the hypoxia response for cancer therapy: the new kid on the block. Clin Cancer Res 2009, 15:5945-5946. 10.1158/1078-0432.CCR-09-1650, 19789327.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5945-5946
-
-
Koh, M.Y.1
Spivak-Kroizman, T.R.2
Powis, G.3
-
15
-
-
33847023140
-
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
-
10.1158/0008-5472.CAN-06-4744, 17283112
-
Dewhirst MW. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res 2007, 67:854-855. 10.1158/0008-5472.CAN-06-4744, 17283112.
-
(2007)
Cancer Res
, vol.67
, pp. 854-855
-
-
Dewhirst, M.W.1
-
16
-
-
3142622930
-
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
-
10.1016/j.ccr.2004.06.009, 15261140
-
Kung AL, Zabludoff SD, France DS, Friedmann SJ, Tanner EA, Vieira A, Cornell-Kennon S, Lee J, Wang B, Wang J, Memmert K, Naegeli HU, Petersen F, Eck MJ, Bair KW, Wood AW, Livingston DM. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 2004, 6:33-43. 10.1016/j.ccr.2004.06.009, 15261140.
-
(2004)
Cancer Cell
, vol.6
, pp. 33-43
-
-
Kung, A.L.1
Zabludoff, S.D.2
France, D.S.3
Friedmann, S.J.4
Tanner, E.A.5
Vieira, A.6
Cornell-Kennon, S.7
Lee, J.8
Wang, B.9
Wang, J.10
Memmert, K.11
Naegeli, H.U.12
Petersen, F.13
Eck, M.J.14
Bair, K.W.15
Wood, A.W.16
Livingston, D.M.17
-
17
-
-
20944449117
-
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
-
10.1016/j.radonc.2005.01.009, 15878106
-
Williams KJ, Telfer BA, Xenaki D, Sheridan MR, Desbaillets I, Peters HJ, Honess D, Harris AL, Dachs GU, van der Kogel A, Stratford IJ. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol 2005, 75:89-98. 10.1016/j.radonc.2005.01.009, 15878106.
-
(2005)
Radiother Oncol
, vol.75
, pp. 89-98
-
-
Williams, K.J.1
Telfer, B.A.2
Xenaki, D.3
Sheridan, M.R.4
Desbaillets, I.5
Peters, H.J.6
Honess, D.7
Harris, A.L.8
Dachs, G.U.9
van der Kogel, A.10
Stratford, I.J.11
-
18
-
-
38349019701
-
Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells
-
10.1186/1471-2407-7-213, 2200672, 17999771
-
Staab A, Loeffler J, Said HM, Diehlmann D, Katzer A, Beyer M, Fleischer M, Schwab F, Baier K, Einsele H, Flentje M, Vordermark D. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells. BMC Cancer 2007, 7:213. 10.1186/1471-2407-7-213, 2200672, 17999771.
-
(2007)
BMC Cancer
, vol.7
, pp. 213
-
-
Staab, A.1
Loeffler, J.2
Said, H.M.3
Diehlmann, D.4
Katzer, A.5
Beyer, M.6
Fleischer, M.7
Schwab, F.8
Baier, K.9
Einsele, H.10
Flentje, M.11
Vordermark, D.12
-
19
-
-
36148961902
-
The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in soft-tissue sarcoma cells in vitro under different oxygen conditions
-
10.1038/sj.cgt.7701090, 17885676
-
Kappler M, Rot S, Taubert H, Greither T, Bartel F, Dellas K, Hänsgen G, Trott KR, Bache M. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in soft-tissue sarcoma cells in vitro under different oxygen conditions. Cancer Gene Ther 2007, 14:994-1001. 10.1038/sj.cgt.7701090, 17885676.
-
(2007)
Cancer Gene Ther
, vol.14
, pp. 994-1001
-
-
Kappler, M.1
Rot, S.2
Taubert, H.3
Greither, T.4
Bartel, F.5
Dellas, K.6
Hänsgen, G.7
Trott, K.R.8
Bache, M.9
|